NBC News @NBCNews
Around 1-2% of people taking Paxlovid in Pfizer's clinical trial tested positive for the coronavirus after testing negative. Rebound rates are around 5% among the tens of thousands of people who've taken the drug in real-life settings. https://t.co/Vpxu0O5enu — PolitiTweet.org